Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease

Journal of Nuclear Medicine

Volumn 38, Issue 5, 1997, Pages 742-748

  Dahl, Juergen Vom ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

myocardial viability; PET; SPECT1 coronary artery disease

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; SCINTIANGIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEART; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0030912580     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Schwaiger M, Brunken R, Grover-McKay M, et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 1986;8:800-808.
2. Brunken R, Tillisch J, Schwaiger M, et al. Regional perfusion, glucose metabolism and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73:951-963.
3. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischémie heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989;32:217-238.
4. Schelbert HR, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation 1988;78:496-505.
5. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-888.
6. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18-deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-865.
7. Nienaber CA, Brunken RC, Sherman CD, et al. Metabolic and functional recovery of ischémie human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18: 966-978.
8. Marwick TH, Maclntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation 1992;85:13471353.
9. Carrel T, Jenni R, Haubold-Reuter S, von Schulthess G, Pasic M, Turina M. Improvement of severely reduced left ventricular function after surgical revascular-ization in patients with preoperative myocardial infarction. Eur. J Cardio-thonw Sun; 1992;6:479-484.
10. (jropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993:22:1587 1597.
11. vom Dahl J, Eitzman DT, Al-Aouar ZR, Kanter HL. Hicks RJ, Schwaiger M. Relationship between regional function, perfusion and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994:90:2355-2366.
12. Hit/man D, Al-Aouar ZR, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.,/ Am Coll Cardiol 1992:20:559-565.
13. Tamaki N, Kawamoto M, Takahashi N, et al. Prognostic value of an increase in fluorine-18-deoxyglucosc uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993;22:1621-1627.
14. DiCarli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-533.
15. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-2694.
16. Lucignani G, Paolini G, Landoni C, et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single-photon emission computed tomography and fluorine-18-fluoro-2-deoxy-Dglucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992;19:874-881.
17. Altehoefer C, vom Dahl J, Biedermann M, et al. Significance of defect severity in Technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. ./ Nucl Med 1994:35:569-574.
18. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of Tc-99m-sestamibi with thallium reinjection and F-18 fluorodeoxyglucose. Circulation 1994;89:578-587.
19. Sawada SG, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m-sestamibi defects. J Am Coll Cardiol 1994;23:92-98.
20. Knuuti MJ, Saraste M, Nuutila P, et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 1994:127:785-796.
21. vom Dahl J, Altehoefer C, Sheehan FH, et al. Recovery of regional left ventricular dysfunction following coronary revascularization: impact of myocardial viability assessed by nuclear imaging and of vessel patency at follow-up. J Am Coll Cardiol 1996;28:948-958.
22. Stirner H, Buell U, Kleinhans E. Three-dimensional ROI-based quantification of stress/rest 2()IT1 myocardial SPECT: presentation of a method. Nuklearmedizin 1986;25:128-133.
23. 99mTc-MIBI SPECT after revascularization in patients with old myocardial infarction. Am J Cardiol 1996;77:88 91.
24. Buell U, Fouroutan Y, Hellwig D, et al. Comparison of relative F-18 FDG uptake to metabolic rate (MRGlucose) in the myocardium in CAD, classified by Tc-99m sestamibi. Nuklearmedizin 1995;34:223-228.
25. Sheehan FH, Mathey DG, Schofer J, Krebber H-J, Dodge HT. Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. Am J Cardiol 1983;52:431-438.
26. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 1986;74:293-305.
27. vom Dahl J, Uebis R, Sheehan FH, et al. Factors influencing outcome of regional wall motion following percutaneous transluminal coronary angioplasty. Coron Artery Din 1992;3:489-498.
28. Schwarz ER, Schaper J, vom Dahl J, et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 1996;27:1577-1585.
29. Campeau L. Grading of angina pectoris. Circulation 1976;54:522-523.
30. New York Heart Association Criteria Committee. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 9th ed. Boston: Little Brown Co., 1994; 114.
31. Reinhardi M, Ganschow U, Vester E, et al. Mismatch between glucose metabolism and perfusion in arrhythmogenic foci of patients with ventricular tachycardias [Abstract]. Eur J Nucl Med 1994;21:726.
32. Schwarz ER, Schaper J, vom Dahl J, et al. Hibernating myocardium requires timely revascularization [Abstract]. Eur Heart J 1996;17(suppl):102.
33. Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995;75:1214-1219.
34. Schneider CA, Voth E, Theissen P, et al. Assessment of myocardial viability in patients with chronic myocardial infarction by F-18 fluoro-D-glucose positron emission tomography and Tc-99m MIBI-SPECT. Z Kardiol 1994;83:124-131.